1,341
Views
3
CrossRef citations to date
0
Altmetric
Oncology

Evaluation of the health economic impact of initial diagnostic modality selection in patients suspected of having HCC in China and the USA

, , , , , & show all
Pages 1015-1029 | Received 14 Dec 2021, Accepted 03 Aug 2022, Published online: 19 Aug 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Michael Blankenburg, Mostafa Elhamamy, Diana Zhang, Naoto Fujikawa, Alice Corbin, Guanyi Jin, James Harris & Gesine Knobloch. (2023) Evaluation of health economic impact of initial diagnostic modality selection for colorectal cancer liver metastases in suspected patients in China, Japan and the USA. Journal of Medical Economics 26:1, pages 219-232.
Read now

Articles from other publishers (2)

Fengrong Chen, Jiong Jiang, Dong Liu, Hong Li, Lei Dong, Yahua Song, Ying Zhang, Jing Wang, Yun Qin & Gang Zhao. (2024) The lncRNA lnc-TSI antagonizes sorafenib resistance in hepatocellular carcinoma via downregulating miR-4726-5p expression and upregulating KCNMA1 expression. Journal of Molecular Histology 55:1, pages 83-96.
Crossref
Wenbin Liu, Zhiguo Xie, Kefeng Shen, Lizhu Jiang, Chongyan Liu, Yongsheng Ge, Jihai Yu, Weidong Jia, Jinliang Ma & Hao Chen. (2023) Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma. Medical Oncology 40:9.
Crossref